IgGenix

IgGenix Secures $40M Funding to Advance Antibody Therapy to Treat Food...

Dave Bloom - 2023/02/07

IgGenix, a San Francisco-based biotech company, announced yesterday they had secured $40 million in Series B funding to bring a peanut allergy candidate to...

IgGenix Shows Potential of Platform to Advance Understanding of Tree Nut...

Dave Bloom - 2022/07/05

The company is aiming at more targeted therapeutic approaches that have the potential to address key allergens directly.

Company Developing Therapy to Prevent “Allergic Cascade” Emerges from Stealth Mode

Dave Bloom - 2020/08/04

IgGenix will develop a therapy that focuses on all types of food allergies and related conditions.

Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of service and Privacy Policy.

SnackSafely.com, PO Box 141, Hillsdale, NJ 07642

Tag: IgGenix

IgGenix Secures $40M Funding to Advance Antibody Therapy to Treat Food...

IgGenix Shows Potential of Platform to Advance Understanding of Tree Nut...

Company Developing Therapy to Prevent “Allergic Cascade” Emerges from Stealth Mode